Found: 33
Select item for more details and to access through your institution.
A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Corrigendum to "Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer".
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/6725209
- By:
- Publication type:
- Article
Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/6421205
- By:
- Publication type:
- Article
Mucinous Histology, BRCA1/2 Mutations, and Elevated Tumor Mutational Burden in Colorectal Cancer.
- Published in:
- Journal of Oncology, 2020, p. 1, doi. 10.1155/2020/6421205
- By:
- Publication type:
- Article
Rapid Clearing for High Resolution 3D Imaging of Ex Vivo Pancreatic Cancer Spheroids.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 20, p. 7703, doi. 10.3390/ijms21207703
- By:
- Publication type:
- Article
Topical doxycycline foam 4% for prophylactic management of epidermal growth factor receptor inhibitor skin toxicity: an exploratory phase 2, randomized, double-blind clinical study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Molecular Profiling-Selected Therapy for Treatment of Advanced Pancreaticobiliary Cancer: A Retrospective Multicenter Study.
- Published in:
- BioMed Research International, 2015, v. 2015, p. 1, doi. 10.1155/2015/681653
- By:
- Publication type:
- Article
Multiplexed, single-molecule, epigenetic analysis of plasma-isolated nucleosomes for cancer diagnostics.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 2, p. 212, doi. 10.1038/s41587-022-01447-3
- By:
- Publication type:
- Article
Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Author Correction: ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
ChIP-seq of plasma cell-free nucleosomes identifies gene expression programs of the cells of origin.
- Published in:
- Nature Biotechnology, 2021, v. 39, n. 5, p. 586, doi. 10.1038/s41587-020-00775-6
- By:
- Publication type:
- Article
The mental health of breast cancer survivors and their adolescent daughters.
- Published in:
- Psycho-Oncology, 2013, v. 22, n. 6, p. 1236, doi. 10.1002/pon.3127
- By:
- Publication type:
- Article
Agents of support: psychometric properties of the Cancer Perceived Agents of Social Support (CPASS) questionnaire.
- Published in:
- Psycho-Oncology, 2010, v. 19, n. 11, p. 1179, doi. 10.1002/pon.1668
- By:
- Publication type:
- Article
How relevant is marital status and gender variables in coping with colorectal cancer? A sample of middle-aged and older cancer survivors.
- Published in:
- Psycho-Oncology, 2009, v. 18, n. 8, p. 866, doi. 10.1002/pon.1499
- By:
- Publication type:
- Article
Screening for germline mutations in breast/ovarian cancer susceptibility genes in high-risk families in Israel.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 155, n. 1, p. 133, doi. 10.1007/s10549-015-3662-2
- By:
- Publication type:
- Article
A universal cell‐free DNA approach for response prediction to preoperative chemoradiation in rectal cancer.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 7, p. 1444, doi. 10.1002/ijc.34392
- By:
- Publication type:
- Article
Defects in homologous recombination repair genes are associated with good prognosis and clinical sensitivity to DNA-damaging agents in pancreatic cancer: A case report.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Polyglutamine repeat length in the AIB1 gene modifies breast cancer susceptibility in BRCA1 carriers.
- Published in:
- International Journal of Cancer, 2004, v. 108, n. 3, p. 399, doi. 10.1002/ijc.11531
- By:
- Publication type:
- Article
Beyond KRAS: Practical Molecular Targets in Pancreatic Adenocarcinoma.
- Published in:
- Case Reports in Oncology, 2019, v. 12, n. 1, p. 7, doi. 10.1159/000496018
- By:
- Publication type:
- Article
Lynch Syndrome in high risk Ashkenazi Jews in Israel.
- Published in:
- Familial Cancer, 2014, v. 13, n. 1, p. 65, doi. 10.1007/s10689-013-9675-2
- By:
- Publication type:
- Article
An Ashkenazi founder mutation in the MSH6 gene leading to HNPCC.
- Published in:
- Familial Cancer, 2010, v. 9, n. 2, p. 141, doi. 10.1007/s10689-009-9298-9
- By:
- Publication type:
- Article
Response to neo-adjuvant chemotherapy in BRCA1 and BRCA2 related stage III breast cancer.
- Published in:
- Familial Cancer, 2009, v. 8, n. 3, p. 173, doi. 10.1007/s10689-008-9223-7
- By:
- Publication type:
- Article
Mutation spectrum in HNPCC in the Israeli population.
- Published in:
- Familial Cancer, 2008, v. 7, n. 4, p. 309, doi. 10.1007/s10689-008-9191-y
- By:
- Publication type:
- Article
An observational cohort study of bevacizumab and chemotherapy in metastatic colorectal cancer patients: safety and efficacy with analysis by age group.
- Published in:
- Targeted Oncology, 2015, v. 10, n. 1, p. 55, doi. 10.1007/s11523-014-0311-3
- By:
- Publication type:
- Article
A fully 3D-printed versatile tumor-on-a-chip allows multi-drug screening and correlation with clinical outcomes for personalized medicine.
- Published in:
- Communications Biology, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s42003-023-05531-5
- By:
- Publication type:
- Article
Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. e696, doi. 10.1634/theoncologist.2018-0351
- By:
- Publication type:
- Article
Retrospective Study of the Predictive Value of Target Now® in Systemic Therapy for Metastatic Colorectal and Gastric Carcinomas.
- Published in:
- Israel Medical Association Journal, 2015, v. 17, n. 10, p. 612
- By:
- Publication type:
- Article
TL-118-anti-angiogenic treatment in pancreatic cancer: a case report.
- Published in:
- Medical Oncology, 2013, v. 30, n. 2, p. 1, doi. 10.1007/s12032-013-0585-9
- By:
- Publication type:
- Article
Hypertension as a predictive biomarker in bevacizumab treatment for colorectal cancer patients.
- Published in:
- Medical Oncology, 2013, v. 30, n. 1, p. 1, doi. 10.1007/s12032-012-0327-4
- By:
- Publication type:
- Article
Long-term outcome of continuous 5-fluorouracil/cisplatin-based chemotherapy followed by chemoradiation in patients with resected gastric cancer.
- Published in:
- Medical Oncology, 2012, v. 29, n. 5, p. 3035, doi. 10.1007/s12032-012-0302-0
- By:
- Publication type:
- Article
H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
H19-Promoter-Targeted Therapy Combined with Gemcitabine in the Treatment of Pancreatic Cancer.
- Published in:
- ISRN Oncology, 2012, p. 1, doi. 10.5402/2012/351750
- By:
- Publication type:
- Article
Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review.
- Published in:
- OncoTargets & Therapy, 2020, v. 13, p. 11637, doi. 10.2147/OTT.S276814
- By:
- Publication type:
- Article